Related Experiment Videos

[Age, an independent risk factor for thrombosis. Epidemiologic data]

I Mahé1, C Caulin, J F Bergmann

  • 1Service de Médecine A, Hôpital Lariboisière, Paris (75). isabelle.mahe@lrb.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|August 16, 2005
PubMed

Insights

The risk of arterial and venous thrombosis significantly increases with age, particularly in individuals over 80. Early identification of risk factors is crucial for preventing thrombotic events in the elderly.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Hematology

Context:

  • Thrombosis incidence, both arterial and venous, escalates with advancing age.
  • Elderly populations exhibit a higher prevalence of conditions predisposing to thrombosis, such as atheromatous diseases and atrial fibrillation.
  • Ischemic heart disease is a leading cause of mortality in older adults.

Purpose:

  • To highlight the age-related increase in thrombotic event risk.
  • To emphasize the significance of atrial fibrillation as a risk factor for cerebrovascular accidents in the elderly.
  • To underscore the rising incidence of venous thromboembolic disease with age.

Summary:

  • The incidence of arterial and venous thrombosis rises with age, with conditions like atrial fibrillation and venous thromboembolic disease becoming more prevalent.
  • Atrial fibrillation affects approximately 10% of individuals over 80, increasing stroke risk.
  • Venous thromboembolic disease incidence rises significantly in those over 75.
  • Elderly individuals frequently possess multiple risk factors, amplifying their thrombotic event risk.

Impact:

  • Recognizing the heightened risk of thrombosis in the elderly necessitates systematic screening for acquired risk factors.
  • Proactive assessment and management of risk factors are essential for effective prevention strategies in geriatric populations.
  • This understanding supports targeted interventions to mitigate the burden of thrombotic diseases in aging societies.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...